Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44


Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors.

Majhail NS, Brunstein CG, Shanley R, Sandhu K, McClune B, Oran B, Warlick ED, Wagner JE, Weisdorf DJ.

Bone Marrow Transplant. 2012 Apr;47(4):494-8. doi: 10.1038/bmt.2011.114. Epub 2011 May 23.


An overview of the progress on double umbilical cord blood transplantation.

Sideri A, Neokleous N, Brunet De La Grange P, Guerton B, Le Bousse Kerdilles MC, Uzan G, Peste-Tsilimidos C, Gluckman E.

Haematologica. 2011 Aug;96(8):1213-20. doi: 10.3324/haematol.2010.038836. Epub 2011 May 5. Review.


Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine SM, Wingard JR, Aljitawi OS, Cutler CS, Jagasia MH, Ballen KK, Eapen M, O'Donnell PV; Blood and Marrow Transplant Clinical Trials Network.

Blood. 2011 Jul 14;118(2):282-8. doi: 10.1182/blood-2011-03-344853. Epub 2011 Apr 28.


Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin.

Sauter C, Abboud M, Jia X, Heller G, Gonzales AM, Lubin M, Hawke R, Perales MA, van den Brink MR, Giralt S, Papanicolaou G, Scaradavou A, Small TN, Barker JN.

Biol Blood Marrow Transplant. 2011 Oct;17(10):1460-71. doi: 10.1016/j.bbmt.2011.02.001. Epub 2011 Mar 1.


Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.

Oran B, Wagner JE, DeFor TE, Weisdorf DJ, Brunstein CG.

Biol Blood Marrow Transplant. 2011 Sep;17(9):1327-34. doi: 10.1016/j.bbmt.2011.01.007. Epub 2011 Jan 11.


Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.

Avery S, Shi W, Lubin M, Gonzales AM, Heller G, Castro-Malaspina H, Giralt S, Kernan NA, Scaradavou A, Barker JN.

Blood. 2011 Mar 24;117(12):3277-85; quiz 3478. doi: 10.1182/blood-2010-08-300491. Epub 2010 Dec 13.


Novel cord blood transplant therapies.

Shpall EJ, Bollard CM, Brunstein C.

Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S39-45. doi: 10.1016/j.bbmt.2010.10.004. Epub 2010 Oct 15. Review. No abstract available.


Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.

Robin M, Sanz GF, Ionescu I, Rio B, Sirvent A, Renaud M, Carreras E, Milpied N, Mohty M, Beguin Y, Bordigoni P, de Witte T, Picardi A, Purtill D, Gluckman E, Kroger N, Rocha V.

Leukemia. 2011 Jan;25(1):75-81. doi: 10.1038/leu.2010.219. Epub 2010 Sep 30.


Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Kanda J, Rizzieri DA, Gasparetto C, Long GD, Chute JP, Sullivan KM, Morris A, Smith CA, Hogge DE, Nitta J, Song K, Niedzwiecki D, Chao NJ, Horwitz ME.

Biol Blood Marrow Transplant. 2011 Jun;17(6):867-74. doi: 10.1016/j.bbmt.2010.09.009. Epub 2010 Sep 22.


Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?

Willemze R, Ruggeri A, Purtill D, Rodrigues CA, Gluckman E, Rocha V; Eurocord and of the European Group of Blood and Marrow Transplantation.

Best Pract Res Clin Haematol. 2010 Jun;23(2):283-90. doi: 10.1016/j.beha.2010.05.005. Review.


Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, Verneris MR, Appelbaum FR, Wagner JE, Delaney C.

Blood. 2010 Nov 25;116(22):4693-9. doi: 10.1182/blood-2010-05-285304. Epub 2010 Aug 4.


Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE; Center for International Blood and Marrow Transplant Research; Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation); National Cord Blood Program of the New York Blood Center.

Lancet Oncol. 2010 Jul;11(7):653-60. doi: 10.1016/S1470-2045(10)70127-3.


Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries.

Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS.

Bone Marrow Transplant. 2011 Jan;46(1):70-6. doi: 10.1038/bmt.2010.83. Epub 2010 May 3.


New approaches for improving engraftment after cord blood transplantation.

Rocha V, Broxmeyer HE.

Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S126-32. doi: 10.1016/j.bbmt.2009.11.001. Epub 2009 Nov 5. Review.


Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Gutman JA, Turtle CJ, Manley TJ, Heimfeld S, Bernstein ID, Riddell SR, Delaney C.

Blood. 2010 Jan 28;115(4):757-65. doi: 10.1182/blood-2009-07-228999. Epub 2009 Oct 12.


Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.

Rocha V, Gluckman E; Eurocord-Netcord registry and European Blood and Marrow Transplant group.

Br J Haematol. 2009 Oct;147(2):262-74. doi: 10.1111/j.1365-2141.2009.07883.x. Review.


Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

Verneris MR, Brunstein CG, Barker J, MacMillan ML, DeFor T, McKenna DH, Burke MJ, Blazar BR, Miller JS, McGlave PB, Weisdorf DJ, Wagner JE.

Blood. 2009 Nov 5;114(19):4293-9. doi: 10.1182/blood-2009-05-220525. Epub 2009 Aug 25.


High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.

Delaney M, Cutler CS, Haspel RL, Yeap BY, McAfee SL, Dey BR, Attar E, Kao G, Alyea EP, Koreth J, Ho VT, Saidman S, Liney D, Sese D, Soiffer RJ, Spitzer TR, Antin JH, Ballen KK.

Transfusion. 2009 May;49(5):995-1002. doi: 10.1111/j.1537-2995.2008.02077.x. Epub 2009 Jan 21.


Graft Failure after Allogeneic Hematopoietic Cell Transplantation.

Mattsson J, Ringdén O, Storb R.

Biol Blood Marrow Transplant. 2008 Jan;14(Supplement 1):165-170.


Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.

Rodrigues CA, Sanz G, Brunstein CG, Sanz J, Wagner JE, Renaud M, de Lima M, Cairo MS, Fürst S, Rio B, Dalley C, Carreras E, Harousseau JL, Mohty M, Taveira D, Dreger P, Sureda A, Gluckman E, Rocha V.

J Clin Oncol. 2009 Jan 10;27(2):256-63. doi: 10.1200/JCO.2007.15.8865. Epub 2008 Dec 8. Erratum in: J Clin Oncol. 2009 Apr 10;27(11):1923.

Items per page

Supplemental Content

Support Center